News & Publications

FDA Was Right to Deny Petition to Restrict Animal Antibiotics (via OpenMarket.org)

Greg Conko of the Competitive Enterprise Institute writes, “I would still argue that FDA made the right call, but for an incomplete reason. In response to both the 1999 and 2005 petitions, the agency essentially said that going through the formal legal process to revoke the approvals for a drug is intensive, time consuming, and a poor use of FDA resources. And because the agency already monitors the development of resistance and has both nominally voluntary and explicitly mandatory programs in place to restrict uses that may pose realistic threats to human health, FDA argued that beginning the revocation process isn’t worth it.”

Read more at OpenMarket.org.

Speak Your Mind

*


− eight = 1